Back
Trevi Therapeutics Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
69
TRVI
Trevi Therapeutics
Last Price:
$6.46
Seasonality Move:
20.26%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
The current trend is moderately bearish and TRVI is experiencing slight buying pressure.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.74 | Sell |
| 20-day SMA: | 6.46 | Buy |
| 50-day SMA: | 6.09 | Buy |
| 200-day SMA: | 4.05 | Buy |
| 8-day EMA: | 6.65 | Buy |
| 20-day EMA: | 6.48 | Buy |
| 50-day EMA: | 5.99 | Buy |
| 200-day EMA: | 4.43 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 58.13 | Buy |
| Chaikin Money Flow: | 106569 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.76 - 6.76) | Buy |
| Bollinger Bands (100): | (3.97 - 6.25) | Buy |
Trevi Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.70 while TRVI 8-day simple moving average is 6.74, which is a Sell signal.
-
The stock price of TRVI is 6.70 while Trevi Therapeutics 20-day SMA is 6.46, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 6.09 while TRVI share price is 6.70, making it a Buy technically.
-
TRVI stock price is 6.70 and Trevi Therapeutics 200-day simple moving average is 4.05, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
69
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $6.70. The Score for TRVI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
681.7M
Price in USD:
6.70
Share Volume:
1.2M
Trevi Therapeutics 52-Week Range
52-Week High:
7.39
52-Week Low:
2.30
Buy
69
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 6.70 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.70 while TRVI 8-day exponential moving average is 6.65, which is a Buy signal.
-
The stock price of TRVI is 6.70 while Trevi Therapeutics 20-day EMA is 6.48, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 5.99 while TRVI share price is 6.70, making it a Buy technically.
-
TRVI stock price is 6.70 and Trevi Therapeutics 200-day simple moving average is 4.43, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 58.13, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (5.76 - 6.76), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (3.97 - 6.25), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.